| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/24/1997 | DE19539363A1 Verfahren zur Herstellung von festen Arzneiformen A process for the preparation of solid medicinal forms |
| 04/24/1997 | DE19539362A1 Verfahren zur Herstellung von festen Arzneiformen A process for the preparation of solid medicinal forms |
| 04/24/1997 | DE19539361A1 Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung A process for producing multilayer, solid drug forms for oral or rectal administration |
| 04/24/1997 | DE19539360A1 Verfahren zur Herstellung von festen Arzneiformen A process for the preparation of solid medicinal forms |
| 04/24/1997 | DE19539359A1 Formbandkalander Formbandkalander |
| 04/24/1997 | CA2235071A1 Analgesic immediate and controlled release pharmaceutical composition |
| 04/24/1997 | CA2232746A1 Liquid cristal cosmetic composition |
| 04/24/1997 | CA2232424A1 Cosmetic composition for the treatment of keratinous materials comprising at least a grafted silicone polymer and at least an aqueous dispersion of insoluble particles of non ionic or cationic polymer |
| 04/24/1997 | CA2188587A1 Support and composition containing said support and a stabilized cosmetic or dermatological ingredient |
| 04/23/1997 | EP0769299A1 Remedy for allergic diseases in the region of the nose |
| 04/23/1997 | EP0769294A1 Taste-masked aqueous solutions comprising methol |
| 04/23/1997 | EP0769063A1 Targeted gene delivery system |
| 04/23/1997 | EP0768896A2 Low-dose steroid tablets containing gallic acid esters as antioxidant agent, process for the manufacture of said tablets, and uses of said tablets |
| 04/23/1997 | EP0768888A1 Use of muramyl peptide compounds |
| 04/23/1997 | EP0768882A1 Carbamazepine medicament with retarded active substance release |
| 04/23/1997 | EP0768880A1 Tacrine pharmaceutical compositions |
| 04/23/1997 | EP0768876A1 Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same |
| 04/23/1997 | EP0768873A1 A method for treating capsules used for drug storage |
| 04/23/1997 | EP0768872A1 New oral pharmaceutical formulation containing magnesium salt of omeprazole |
| 04/23/1997 | EP0768871A1 Method and device for implantation of large diameter objects in bovines |
| 04/23/1997 | EP0768870A1 Multiple encapsulation of oleophilic substances |
| 04/23/1997 | EP0768869A1 Factor to grow tissue ex vivo |
| 04/23/1997 | EP0768868A1 Pharmaceutical preparation with a hydrophobic active substance and an effervescent system, and process for preparing said preparation |
| 04/23/1997 | EP0768867A1 Dosage form for administering drug in liquid formulation |
| 04/23/1997 | EP0768859A1 Controlled release device |
| 04/23/1997 | EP0768858A1 Capsule construction |
| 04/23/1997 | EP0768850A1 Device for the release of an active agent |
| 04/23/1997 | EP0768826A1 Cold water-dispersible compositions of fat-soluble active substances |
| 04/23/1997 | EP0768819A1 Combined virustatic antimediator (covam) treatment of common colds |
| 04/23/1997 | EP0708627A4 Method and device for providing nicotine replacement therapy transdermally/transbuccally |
| 04/23/1997 | EP0684815A4 Drug delivery system using hollow fibers. |
| 04/23/1997 | EP0684806A4 Transmucosal delivery of macromolecular drugs. |
| 04/23/1997 | EP0651635B1 Patch for low-melting and/or volatile active substances |
| 04/23/1997 | EP0600873B1 Therapeutically effective topical application of st1435 |
| 04/23/1997 | EP0596903B1 Transdermal therapeutic systems |
| 04/23/1997 | EP0583399A4 Taste-masked medicaments and their preparation |
| 04/23/1997 | EP0514465B1 Foamable composition for pharmaceutical use, use thereof and method of treatment |
| 04/23/1997 | EP0505374B1 Vitamin-mineral treatment methods and compositions |
| 04/23/1997 | CN1148377A Omega-hydrofluoroalkyle ethers, precursor carboxylic acid and derivatives thereof, and their prepn. and application |
| 04/23/1997 | CN1148344A New oral pharmaceutical dosage form |
| 04/23/1997 | CN1148341A Oral liquid alendronate formulations |
| 04/23/1997 | CN1148336A Liposome with increased retention volume |
| 04/23/1997 | CN1148335A Mucoadhesive emulsion contg. cyclodextrin |
| 04/23/1997 | CN1147961A Stable liquid composition containing urate oxidase and lyophilized composition for its prepn. |
| 04/23/1997 | CN1147950A Oral liquor for treating and preventing cerebrovascular disease |
| 04/23/1997 | CN1147948A Traditional Chinese medicinal prepn. for relieving swelling and alleviating pain of throat |
| 04/23/1997 | CN1147946A Sichuan aconite root analgesic soft extract |
| 04/23/1997 | CN1147945A Traditional Chinese medicinal bolus for curing rheumatism |
| 04/23/1997 | CN1147944A Traditional Chinese spray medicine for throat |
| 04/23/1997 | CN1147942A Antidiarrheal granular for baby pig and method for preparing same |
| 04/23/1997 | CN1147941A Medicine for curing deficiency of liver and kidney |
| 04/23/1997 | CN1147938A Liquid for giving up smoking |
| 04/23/1997 | CN1147904A Method for producing food, health-care food and medicine from soybean plant, and products therefrom |
| 04/22/1997 | US5623064 Purity; removal of protein |
| 04/22/1997 | US5622993 Stick formulations for topical drug delivery of therapeutic agents and uses thereof |
| 04/22/1997 | US5622992 Administering topical aromatic releasing decongestant composition to treat nasal symptoms |
| 04/22/1997 | US5622990 Dry, roller compacted powder comprising low amount excipients, free of disintegrant |
| 04/22/1997 | US5622980 Oral compositions of H2-antagonists |
| 04/22/1997 | US5622978 Pharmaceutical preparations for the oral administration of dihydropyridines in beverage form |
| 04/22/1997 | US5622963 Innovative technique for immunosuppression involving administration of rapamycin loaded formed blood elements |
| 04/22/1997 | US5622944 Modified 17-hydroxy sterol; transdermal electrotransport enhancement |
| 04/22/1997 | US5622941 Administering the dosage form, nontoxic activated vitamin d; sustain release, side-effect reducation |
| 04/22/1997 | US5622939 Glucan preparation |
| 04/22/1997 | US5622938 Sugar base surfactant for nanocrystals |
| 04/22/1997 | US5622927 Mixture containing folic acid, panthenol and/or allantoin, protein hydrolysate, lactose or dextrose, lactic acid, magnesium sulfate, sodium or ammonium chloride, and a carrier; stability |
| 04/22/1997 | US5622834 Method of isolating poly-β-1-4-N-acetylglucosamine from microalgal culture |
| 04/22/1997 | US5622724 Spraying aqueous or saline solution containing zinc sulfate or zinc chloride to the nostrils or respiratory track of a patient suffering from common cold |
| 04/22/1997 | US5622723 Charging sufficient chlorpheniramine maleate to coacervation medium to saturate cyclohexane solvent, separating microcapsules |
| 04/22/1997 | US5622722 Mixture of water soluble active drug, microcrystalline cellulose and sugar |
| 04/22/1997 | US5622721 Dosage forms of risedronate |
| 04/22/1997 | US5622720 Process for reducing the crystal size of ondansetron hydrochloride dihydrate |
| 04/22/1997 | US5622719 Mixing additive with uncured shearform carrier matrix, molding, crystallization |
| 04/22/1997 | US5622717 Ulcer prevention method using a melt-spun hydrogel |
| 04/22/1997 | US5622716 Sustained release; drug delivery |
| 04/22/1997 | US5622715 Intravenously administering suspension of small unilamellar liposomes composed of phosphatidyl choline phospholipids |
| 04/22/1997 | US5622713 Injecting with buffered solution containing liquid crystalline liposomes |
| 04/22/1997 | US5622712 N-[ω, (ω-1)-dialkyloxy]- and N-[ω, (ω-1)-dialkenyloxy]-alk-1-yl-N, N, N-tetrasubstituted ammonium lipids and uses therefor |
| 04/22/1997 | US5622709 Injectable |
| 04/22/1997 | US5622690 Seed-derived proteinaceous compositions for reduction of sunburn cell formation |
| 04/22/1997 | US5622686 Diagnosis and treatment of viral effects using magnetic metal transferrin particles |
| 04/22/1997 | US5622657 Prolonged release microparticle preparation and production of the same |
| 04/22/1997 | US5622656 Process of manufacture of biodegradable microcapsules having walls composed of crosslinked atelocollagen and polyholosides |
| 04/22/1997 | US5622498 Method for the treatment of periodontal disease by sustained delivery of a therapeutic agent to the periodontal pocket, composition of matter therefor and apparatus for the administration thereof |
| 04/22/1997 | CA2068714C Uncoated pharmaceutical reaction tablet |
| 04/22/1997 | CA2013485C Solid consumer product compositions containing small particle cyclodextrin complexes |
| 04/17/1997 | WO1997013785A1 Transferrin receptor protein of moraxella |
| 04/17/1997 | WO1997013743A1 Polyfunctional cationic cytofectins, formulations and methods for generating active cytofectin: polynucleotide transfection complexes |
| 04/17/1997 | WO1997013548A1 Hydrogels or lipogels with enhanced mass transfer for transdermal drug delivery |
| 04/17/1997 | WO1997013531A1 Solid, orally administrable viral vaccines and methods of preparation |
| 04/17/1997 | WO1997013528A1 A pharmaceutical composition for administration of an active substance to or through a skin or mucosal surface |
| 04/17/1997 | WO1997013521A1 Absorbable prophylactic composition for protection against ionising or non-ionising electromagnetic waves |
| 04/17/1997 | WO1997013520A1 Fast drying, film forming iodine release solution |
| 04/17/1997 | WO1997013518A1 Treatment of pruritus with vitamin d and analogs thereof |
| 04/17/1997 | WO1997013517A1 Aqueous eye drops containing apafant as principal agent |
| 04/17/1997 | WO1997013516A1 Antibacterial composition for oral administration |
| 04/17/1997 | WO1997013508A1 Topical liquid composition, method for preparing same and uses thereof |
| 04/17/1997 | WO1997013503A1 Synthesis of drug nanoparticles by spray drying |
| 04/17/1997 | WO1997013502A2 Prolonged release of gm-csf |
| 04/17/1997 | WO1997013501A1 Liposomal compositions and methods of using them |
| 04/17/1997 | WO1997013500A2 LIPOSOME FORMULATIONS OF 5β STEROIDS |